Methods Assessed for Detecting Asymptomatic Malaria
By LabMedica International staff writers Posted on 03 May 2017 |

Image: The ABI 7500 Fast Dx real-time PCR instrument (Photo courtesy of Applied Biosystems).
Asymptomatic malaria infection refers to malarial parasitemia of any density in the absence of fever or other acute symptoms in individuals who have not received recent antimalarial treatments.
Sensitive methods for detecting asymptomatic malaria infections are essential for identifying potential transmission reservoirs and obtaining an accurate assessment of malaria epidemiology in low-endemicity areas aiming to eliminate malaria. Polymerase chain reaction (PCR) techniques to detect parasite nucleic acids (DNA or RNA) are among the most commonly used molecular methods.
Scientists at China Medical University and their colleagues recruited 1,005 healthy individuals (344 males and 661 females, ages 1–82 years) living in Kachin Sate, Myanmar between May and November, 2015. Two fingerprick samples were taken, one was processed in a nearby field laboratory, and the other on filter paper, dried and stored. The study compared three molecular detection methods side-by-side, namely nested PCR targeting the ribosomal ribonucleic acid (rRNA) genes, nested RT-PCR to detect parasite rRNA, and capture and ligation probe-PCR (CLIP-PCR) to detect parasite RNA.
Thick and thin blood films stained with Giemsa were prepared and read. For positive slides, parasite density was quantified in 500 white blood cells (WBCs) on thick blood films assuming that 1 µL of blood contains 8,000 WBCs. Total RNA and genomic DNA were extracted from peripheral blood samples. Modified nested PCR (nD-PCR) was performed based on the 18S rRNA gene. For the CLIP-PCR 3-mm circle of dried blood spot on 3 M Whatman filter paper was punched out and lysed with 100-µL lysis mixture. Two RT-PCR methods were used to detect Plasmodium vivax gametocytes in samples. For detection of P. vivax gametocytes in all 1,005 samples, the 645 bp full-length Pvs25 gene was amplified using Pvs25-specific primers. Amplification and detection were performed on an ABI 7500 apparatus.
Light microscopy detected Plasmodium infections in only 1.19% of the residents harboring the parasites. CLIP-PCR had slightly better performance and detected Plasmodium infections in 1.89% of the population. Further improvement was achieved by nested PCR to detect parasite DNA, which detected P. vivax and P. falciparum infections in 2.39% of the residents. The nested RT-PCR targeting rRNA, however, detected as many as 187 (18.61%) individuals having Plasmodium infections with P. vivax being the predominant species (176 P. vivax, five P. falciparum and six P. falciparum/P. vivax mixed infections). Of the 210 Plasmodium-positive samples detected by all molecular methods, 115 were Pvs25-positive by quantitative polymerase chain reaction (qRT-PCR), indicating that a large proportion of asymptomatic individuals were gametocyte carriers.
The authors concluded that Nested RT-PCR based on the detection of asexual-stage parasite rRNA was the most sensitive, with a more than six-fold higher sensitivity than the other two molecular methods of parasite detection. CLIP-PCR has an increased throughput, but its sensitivity in this study was much lower than those of other molecular methods. The study was published on April 20, 2017, in the Malaria Journal.
Sensitive methods for detecting asymptomatic malaria infections are essential for identifying potential transmission reservoirs and obtaining an accurate assessment of malaria epidemiology in low-endemicity areas aiming to eliminate malaria. Polymerase chain reaction (PCR) techniques to detect parasite nucleic acids (DNA or RNA) are among the most commonly used molecular methods.
Scientists at China Medical University and their colleagues recruited 1,005 healthy individuals (344 males and 661 females, ages 1–82 years) living in Kachin Sate, Myanmar between May and November, 2015. Two fingerprick samples were taken, one was processed in a nearby field laboratory, and the other on filter paper, dried and stored. The study compared three molecular detection methods side-by-side, namely nested PCR targeting the ribosomal ribonucleic acid (rRNA) genes, nested RT-PCR to detect parasite rRNA, and capture and ligation probe-PCR (CLIP-PCR) to detect parasite RNA.
Thick and thin blood films stained with Giemsa were prepared and read. For positive slides, parasite density was quantified in 500 white blood cells (WBCs) on thick blood films assuming that 1 µL of blood contains 8,000 WBCs. Total RNA and genomic DNA were extracted from peripheral blood samples. Modified nested PCR (nD-PCR) was performed based on the 18S rRNA gene. For the CLIP-PCR 3-mm circle of dried blood spot on 3 M Whatman filter paper was punched out and lysed with 100-µL lysis mixture. Two RT-PCR methods were used to detect Plasmodium vivax gametocytes in samples. For detection of P. vivax gametocytes in all 1,005 samples, the 645 bp full-length Pvs25 gene was amplified using Pvs25-specific primers. Amplification and detection were performed on an ABI 7500 apparatus.
Light microscopy detected Plasmodium infections in only 1.19% of the residents harboring the parasites. CLIP-PCR had slightly better performance and detected Plasmodium infections in 1.89% of the population. Further improvement was achieved by nested PCR to detect parasite DNA, which detected P. vivax and P. falciparum infections in 2.39% of the residents. The nested RT-PCR targeting rRNA, however, detected as many as 187 (18.61%) individuals having Plasmodium infections with P. vivax being the predominant species (176 P. vivax, five P. falciparum and six P. falciparum/P. vivax mixed infections). Of the 210 Plasmodium-positive samples detected by all molecular methods, 115 were Pvs25-positive by quantitative polymerase chain reaction (qRT-PCR), indicating that a large proportion of asymptomatic individuals were gametocyte carriers.
The authors concluded that Nested RT-PCR based on the detection of asexual-stage parasite rRNA was the most sensitive, with a more than six-fold higher sensitivity than the other two molecular methods of parasite detection. CLIP-PCR has an increased throughput, but its sensitivity in this study was much lower than those of other molecular methods. The study was published on April 20, 2017, in the Malaria Journal.
Latest Molecular Diagnostics News
- RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
- First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
- Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
- Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
- Blood Test Rules Out Future Dementia Risk
- D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
- New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
- Chemiluminescence Immunoassays Support Diagnosis of Alzheimer’s Disease
- Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury
- Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression
- Simple DNA PCR-Based Lab Test to Enable Personalized Treatment of Bacterial Vaginosis
- Rapid Diagnostic Test to Halt Mother-To-Child Hepatitis B Transmission
- Simple Urine Test Could Help Patients Avoid Invasive Scans for Kidney Cancer
- New Bowel Cancer Blood Test to Improve Early Detection
- Refined Test Improves Parkinson’s Disease Diagnosis
- New Method Rapidly Diagnoses CVD Risk Via Molecular Blood Screening
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more